Platforms
Built for Speed and Scale: How CDMO Cell Line Platforms Are Reshaping Biologic Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-25-NI-05Jul 15, 2025
CLD
Advancing Biologics Development With Next-Generation Cell Line Development
Woo Chi, Ph.D.; Yingji Jin, Ph.D.; Jaeeun Kim
Samsung Biologics
PAO-06-25-CL-06Jun 16, 2025
Cell Line
Abzena Strengthens Specialized Bioassay Offering Through Access Agreement with Major Cell Line Depository
Abzena
PR-M03-18-NI-053Mar 15, 2018
CRISPR
Charles River Expands CRISPR Offerings with Second License
Nice Insight
PAO-M12-17-NI-022Dec 15, 2017
Cell Line Development
Abzena and UGA Team Up to Develop MS Therapeutic
Nice Insight
PAO-M10-17-NI-033Oct 24, 2017
Biologics
Propagating a Full Spectrum of Services for ADC Development and Manufacture
John Manzello; Campbell Bunce
Abzena
PAP-Q2-17-CL-007Jun 05, 2017
Cell Line Development for Therapeutic Recombinant Proteins
Carrie Cao, Ph.D.
Nice Insight
MCP-M02-17-NI-001Feb 02, 2017